Page 7 - Read Online
P. 7

Page 2 of 8            Grünherz et al. Plast Aesthet Res 2023;10:20  https://dx.doi.org/10.20517/2347-9264.2023.24

               Thoracic duct injuries typically occur in the setting of head and neck surgery such as neck dissection,
               pharyngectomy, esophagectomy or thyroidectomy or after heart surgery. After lateral neck dissection, the
               incidence is 4.5-8.3%, with the risk increasing with the presence of metastases at the angulus venosus as well
                                   [3-8]
               as the extent of surgery . Depending on the anatomic location involved, patients suffer from leakage of
               chyle in the area of the surgical wound, recurrent thoracic (chylothorax) or abdominal chylous effusions
               (chylous ascites), which favor infections and further complications due to permanent protein and fluid loss
               leading to a mortality of up to 50% [9-10] .


               Lesions of the central lymphatic system or lymphatic dysfunction due to high venous pressure can also
               result from Fontan surgery in patients with congenital heart disease with single-ventricle physiology. In
               these patients, lymphatic dysfunction can lead to hepatic lymphatic congestion, protein-losing enteropathy
               and plastic bronchitis due to the formation of rubbery and caulk-like plugs in the airways, causing severe
               respiratory issues. Protein-losing enteropathy is caused by permanent enteric protein loss, resulting in
                                                                                        [11]
               hypoalbuminemia, lymphopenia, hypogammaglobulinemia, and loss of clotting factors .

               Congenital malformations of the lymphatic system include central conducting lymphatic anomalies (CCLA)
               and lymphocele.


               Due to the rarity of central lymphatic lesions, diagnosis and treatment should be reserved for specialized
               lymphatic centers. In addition to a detailed history, diagnosis is based on special imaging, preferably
               magnetic resonance lymphangiography (MRL), which allows accurate visualization of the central lymphatic
                                                             [12]
               lesion and is essential for precise treatment planning . In the case of lymphatic lesions in childhood, a
                                                       [1]
               broad genetic workup should also be performed .
               TREATMENT ALGORITHM
               We previously established a treatment algorithm based on a series of cases with central lymphatic lesions,
               which is shown in [Figure 1]. Initial treatment of central lymphatic lesions should be based on conservative
               therapy including a diet of medium-chain triglycerides (MCT) or total parenteral nutrition (TPN).
               Although success rates vary widely, this therapy can lead to spontaneous resolution of the chyle leak [13,14] . In
               addition, we propose to combine dietary measures with an Octreotide therapy that is supposed to reduce
               the production of chyle. Especially in patients with central conducting lymphatic anomaly (CCLA), other
               substances such as propanolol, sirolimus, sildenafil or trametinib are increasingly used [15-18] .


               When conservative treatment fails, lymphangiography-guided interventions remain the treatment of choice
               for central lymphatic lesions and allow for different treatment modalities depending on the entity of the
               lesion. Lymphangiography alone has been shown to succeed in different sites of lymphatic leakage due to its
               known Lipiodol-induced selective blockage of pathological lymph ducts.

               Lymphangiography-guided embolization of the affected central lymphatics by endovascular coils or liquid
               embolic agents has been shown to be effective in postoperative chylous fistula, chylothorax, and chylous
               ascites with cure rates of 80-90% and overall complication rate of 7% [19,22] . However, it has to be considered
               that occlusion of the thoracic duct carries the risk of protein-losing enteropathy, lower extremity
               lymphedema, or worsening of lymphatic reflux with a fistula at another site due to the resulting down-
               stream congestion . The same accounts for the surgical ligation of the thoracic duct, which has also been
                               [23]
               performed to treat patients with chyle leaks in the past [8,24] . In recent years, micro- and super-microsurgical
                                                                             [25]
               reconstruction, defined as microsurgery in less than 0.8 mm vessels , has opened new frontiers to
               successfully treat rare central lymphatic lesions by thoracic duct-vein anastomoses.
   2   3   4   5   6   7   8   9   10   11   12